Marshall Wace’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-89,472
| Closed | -$2.82M | – | 2977 |
|
|
2024
Q4 | $2.82M | Buy |
+89,472
| New | +$2.82M | ﹤0.01% | 1209 |
|
|
2024
Q1 | – | Sell |
-58,189
| Closed | -$2.23M | – | 2534 |
|
|
2023
Q4 | $2.23M | Buy |
58,189
+33,906
| +140% | +$1.3M | ﹤0.01% | 978 |
|
|
2023
Q3 | $749K | Buy |
24,283
+3,583
| +17% | +$111K | ﹤0.01% | 1333 |
|
|
2023
Q2 | $654K | Sell |
20,700
-2,668
| -11% | -$84.3K | ﹤0.01% | 1506 |
|
|
2023
Q1 | $852K | Buy |
23,368
+4,768
| +26% | +$174K | ﹤0.01% | 1478 |
|
|
2022
Q4 | $550K | Buy |
18,600
+1,229
| +7% | +$36.4K | ﹤0.01% | 1786 |
|
|
2022
Q3 | $678K | Buy |
+17,371
| New | +$678K | ﹤0.01% | 1942 |
|
|
2021
Q1 | – | Sell |
-13,362
| Closed | -$244K | – | 2582 |
|
|
2020
Q4 | $244K | Sell |
13,362
-2,422
| -15% | -$44.2K | ﹤0.01% | 1569 |
|
|
2020
Q3 | $284K | Buy |
+15,784
| New | +$284K | ﹤0.01% | 1339 |
|
|
2019
Q2 | – | Sell |
-12,201
| Closed | -$224K | – | 1880 |
|
|
2019
Q1 | $224K | Sell |
12,201
-24,353
| -67% | -$447K | ﹤0.01% | 1305 |
|
|
2018
Q4 | $726K | Buy |
+36,554
| New | +$726K | 0.01% | 994 |
|